Event Type
Disclosure
Mandatory
Variant
8-K
and Item 7.01 and the information contained in the press release attached as Exhibit 99.1 is not incorporated by reference into any filing with the U.S. Securit
. Financial Statements and Exhibits (d) Exhibits Exhibits No. Description 99.1 Press Release of Corcept Therapeutics Incorporated, dated February 24 , 202 6 104